UCSD-UCLA: Supplementation with amino acid serine eases neuropathy in diabetic mice
|
STANFORD: NIH grant establishes Stanford Medicine as center of national diabetes training program
|
UAB: Type 1 diabetes: Maintaining the enzyme ACE2 in the gut prevents diabetic blindness
|
VANDERBILT: Study may lead to new diabetes, heart disease treatments
|
WUSTL: Study reveals obesity-related trigger that can lead to diabetes
|
YALE: 3 Things To Know About Teplizumab, the New Diabetes Drug
|
COLUMBIA: Positively Charged Nanomaterials Treat Obesity Anywhere You Want
|
INDIANA: IU research contributes to first FDA-approved drug to delay onset of type 1 diabetes
|
YALE: Following Yale Investigator-led Trials, FDA Approves First Drug To Delay Onset of Type 1 Diabetes
|
BOSTON AREA: An endocrinologist and clinical researcher explores how racism and other social factors affect patients with type 2 diabetes
|